Cardiol Therapeutics (CRDL.TO) Q1 2026 Earnings

31MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.12
-0.11
-0.09
-0.07

Details

Expected EPS
-0.11573737404592002
Actual EPS
-0.07088648336
Surprise EPS
0.04
Surprise Percent
+38.75%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.07088648336 per share for Q1 2026.

0 Comments

Share your thoughts